Greater than 95.0% as determined by SDS-PAGE.
IGF1 A70T Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 70 amino acids and having a molecular mass of Approximately 7.7kDa.
The IGF1 A70T is purified by proprietary chromatographic techniques.
GPETLCGAEL VDALQFVCGD RGFYFNKPTG YGSSSRRAPQ TGIVDECCFR SCDLRRLEMY CAPLKPAKST.
Recombinant human IGF-1, including the A70T mutant, is produced using E. coli expression systems. The recombinant protein is typically purified and lyophilized (freeze-dried) for stability and storage . The molecular weight of IGF-1 is approximately 7.7 kDa, and it consists of a single polypeptide chain containing 70 amino acids .
IGF-1 is known for its mitogenic properties, meaning it stimulates cell proliferation and survival. It has significant effects on muscle, bone, and cartilage tissue, making it a valuable tool in research and therapeutic applications . The A70T mutant of IGF-1 retains these properties but may exhibit different activity levels or stability compared to the wild-type protein.
IGF-1 has been extensively studied for its potential in treating various conditions, including growth deficiencies, muscle wasting, and metabolic disorders. The A70T mutant, like other IGF-1 variants, is used in research to understand its specific effects and potential therapeutic applications .
In summary, Insulin-Like Growth Factor-1, Mutant A70T (Human Recombinant) is a valuable tool in scientific research, offering insights into cell growth, proliferation, and potential therapeutic applications. Its unique properties and stability make it a significant focus of study in the field of endocrinology and beyond.